Abstract
Activity-guided fractionation of Euphorbia humifusa for anti-HBV activity led to the isolation of two novel sesquiterpenoids, named humifusane A (1) and humifusane B (2). Their structures were elucidated by spectral data to show that they have a caryophyllane-type precursor structure. The two new sesquiterpenoids showed anti-HBV activities through specifically inhibiting the secretion of HBsAg in HepG2.2.15.
Copyright © 2010 Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antiviral Agents / pharmacology*
-
Antiviral Agents / therapeutic use
-
Euphorbia / chemistry*
-
Hep G2 Cells
-
Hepatitis B / drug therapy*
-
Hepatitis B / metabolism
-
Hepatitis B Surface Antigens / metabolism*
-
Hepatitis B virus / drug effects*
-
Hepatitis B virus / pathogenicity
-
Humans
-
Molecular Structure
-
Phytotherapy*
-
Sesquiterpenes / isolation & purification
-
Sesquiterpenes / pharmacology*
-
Sesquiterpenes / therapeutic use
Substances
-
Antiviral Agents
-
Hepatitis B Surface Antigens
-
Sesquiterpenes
-
humifusane A
-
humifusane B